Description:
Reference #: 01640
The University of South Carolina is offering licensing opportunities for Cannabis Plant Material as an Agent for Mitigating Metabolic Syndrome.
Background:
A symptom of metabolic syndrome is insulin resistance, defined as the inability of insulin to optimally stimulate the transport of glucose into the body’s cell (hyperinsulinemia or impaired glucose tolerance). This can lead to type II Diabetes and Cardiovascular Disease. The research done has discovered that the Cannabis Plant Material can reduce fasting glucose and insulin and lower the homeostasis model assessment-estimated insulin resistance (HOMA-IR) index. This innovation can be used to mitigate metabolic syndrome and associated Type II Diabetes, Coronary Heart Disease, and Stroke.
Invention Description:
This innovation fights against metabolic syndrome, a condition affecting nearly 100 million individuals in the United States. In collaboration with the National Center for Natural Products Research at the University of Mississippi, a team of researchers has made a remarkable discovery using Cannabis Plant Material. Through a comprehensive study involving obese mice, three distinct treatments were evaluated, the results revealed that Cannabis Plant Material rich in THC significantly reduced fasting glucose and insulin levels, leading to a notable decrease in the homeostasis model assessment-estimated insulin resistance (HOMA-IR) index, thereby indicating improved insulin sensitivity. This innovative invention has the potential to revolutionize the management of metabolic syndrome, offering a promising solution for individuals at risk of type II Diabetes and Cardiovascular Disease.
Potential Applications:
This innovation provides a potential solution to the treatment of metabolic syndrome, including Type II Diabetes, Coronary Heart Disease, and Stroke. By effectively reducing fasting glucose and insulin levels and improving insulin sensitivity in obese mice, our use of Cannabis Plant Material holds promise for addressing this widespread health issue and its associated complications.
Advantages and Benefits:
This idea distinguishes itself by utilizing a natural product, Cannabis Plant Material, as a potential treatment for metabolic syndrome. Its affordability, coupled with its excellent efficacy in reducing fasting glucose and insulin levels and improving insulin sensitivity, makes it an attractive option for potential licensees seeking to enhance patient outcomes and lower healthcare expenses.